On 28 de out. de 2025, NVS reported earnings of 2.25 USD per share (EPS) for Q3 25, missing the estimate of 2.29 USD, resulting in a -2.11% surprise. Revenue reached 13.91 bilhão, compared to an expected 14.31 bilhão, with a -2.81% difference. The market reacted with a -4.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of 1.98 USD, with revenue projected to reach 14.11 bilhão USD, implying an diminuir of -12.00% EPS, and aumentar of 1.41% in Revenue from the last quarter.
FAQ
What were Novartis AG's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Novartis AG reported EPS of $2.25, missing estimates by -2.11%, and revenue of $13.91B, -2.81% below expectations.
How did the market react to Novartis AG's Q3 2025 earnings?
The stock price moved down -4.42%, changed from $129.14 before the earnings release to $123.43 the day after.
When is Novartis AG expected to report next?
The next earning report is scheduled for 04 de fev. de 2026.
What are the forecasts for Novartis AG's next earnings report?
Based on 8
analistas, Novartis AG is expected to report EPS of $1.98 and revenue of $14.11B for Q4 2025.